Inflammation, infection, or both in atherosclerosis: The ROXIS trial in perspective

Journal of Infectious Diseases

Volumn 181, Issue 6 SUPPL. 3, 2000, Pages

  Gurfinkel, Enrique ^a  

^a HOSPITAL UNIVERSITARIO FUNDACIÓN FAVALORO   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; ROXITHROMYCIN;

ANTIBIOTIC THERAPY; ATHEROSCLEROSIS; CONFERENCE PAPER; CONTROLLED STUDY; CORONARY ARTERY DISEASE; HEART MUSCLE ISCHEMIA; HUMAN; INFECTION; INFLAMMATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SEROLOGY;

EID: 0034097997     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315606     Document Type: Conference Paper

References (13)

1. 1. Gurfinkel E, Bozovich G, Macchia A, Manos E, Mautner B. Neopterin levels and the aggresiveness of atherosclerosis in coronary artery disease. Am J Cardiol 1999;83:515-8.
2. 2. van der Wal AC, Becker AE, van der Loos CM, et al. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of dominant plaque morphology. Circulation 1994;89:36-44.
3. 3. Farb A, Burke AP, Tang AL, et al. Coronary plaque erosion without rupture into a lipid core. A frequent cause of coronary thrombosis in sudden coronary death. Circulation 1996;93:1354-63.
4. 4. Davies MJ, Thomas A. Thrombosis and acute coronary lesions in sudden cardiac ischemic death. N Engl J Med 1984;310:1137.
5. 5. Moreno P, Fallon JT. Inflammation in acute coronary syndromes. In: Schultheiss HP, Schwimmbeck P, eds. The role of immune mechanisms in cardiovascular disease. New York: Springer-Verlag. 1997:213-9.
6. 6. Maseri A, Liuzzo G, Biasucci LM. Pathogenic mechanisms in unstable angina. Heart 1999;82(suppl 1):S2-4.
7. 7. Gurfinkel E. Is there something more behind atherosclerotic plaque inflammation? Eur Heart J 1998;19:677-8.
8. 8. Gurfinkel E, Bozovich G, Daroca A, et al. Randomized trial of roxithromycin in non Q-wave coronary syndromes: ROXIS Pilot Study. ROXIS Study Group. Lancet 1997;350:404-7.
9. 9. Saikku P, Mattila K, Nieminen MS, et al. Serological evidence of an association or a novel Chlamydia, TWAR, with coronary heart disease and acute myocardial infarction. Lancet 1988;2:983-6.
10. 10. Gurfinkel E, Bozovich G, Livellara S, Testa E, Beck E, Mautner B. Antibiotic effects on unstable angina. The final report of ROXIS Trial. Eur Heart J 1999;20:121-7.
11. 11. Gupta S, Leatham EW, Carrington D, Mendall MA, Kaski JC, Camm AJ. Elevated Chlamydia pneumoniae antibodies, cardiovascular events and azithromycin in male survivors of myocardial infarction. Circulation 1997;96: 404-7.
12. 12. Kadota JL. Nonantibiotic effects of antibiotics. J Clin Microb Infect 1996; 82(suppl 2):S220-2.
13. 13. Anderson JL, Muhlestein JB, Carlquist J, et al. Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection. Circulation 1999;99:1540-7.